Corporate Finance Advisory - Healthcare & Life Sciences
Industry and market knowledge underpins successful advice
Our Healthcare and Life Sciences corporate finance advisory team, led by David L Jones, provides a dedicated corporate finance advisory service, with an excellent track record of success, driven by strong industry knowledge.
Our team works closely with corporates, management teams, individuals and private equity houses on buy-side and sell-side transactions, as well as JVs and public sector partnerships.
The team provides a full range of financial advisory services to sub-industries including healthcare services, consumer healthcare, pharmaceuticals, biotechnology, and medical devices.
The team is fully integrated with Deloitte’s broader Healthcare and Life Sciences practice.
Read more about Deloitte’s HLS sector insights.
Having a global network of Healthcare and Life Science professionals allows Deloitte to operate at the forefront of the industry and maintain strong relationships with financial investors on a global scale.
Find out more about Deloitte's global HLS platform.
We have been commended for the achievements, innovation and ground breaking work completed across the healthcare arena and the team has been named Corporate Financier of the Year at the HealthInvestor Awards in four out of the previous five years, most recently in 2017, and Financial Advisor of the year by LaingBuisson in 2016. Additionally David Jones was named Dealmaker of the Year at the 2016 HealthInvestor Power50 Awards.
Examples of our work
Deloitte advised Chiltern International on the sale of their clinical trial supplies division to CSM
Deloitte advised Age UK on the disposal of Aid-Call Ltd, the largest B2C telealarm business in the UK, to AXA PPP Healthcare.
Deloitte advised WR Evans on the sale of its pharmacy chain to PCT Healthcare.
Deloitte advised the shareholders of Akari on the sale of 35 care homes to the Carlyle Group.
Deloitte advised Capita plc on the sale of its forensic medical staffing business, Tascor Medical Services, to MITIE plc.
Deloitte advised Wright Medical on the divestment of its French subsidiary Tornier to Corin Orthopaedics.
Deloitte provided buy-side advise to CBPE on the acquisition of occupational health business OH Assist from Atos.
Deloitte advised on the disposal of the addiction treatment centre Life Works to the Priory Group.
Exemplar Health Care
Deloitte advised the shareholders of Exemplar Health Care, a UK provider of residential nursing care for adults with acute physical and mental disabilities (PMD) and learning disabilities (LD), on a management buyout backed by Agilitas Private Equity.
Deloitte advised Bupa on the sale of Surgichem, a supplier of medication management systems, to US-based Omnicell Inc.
Executive Care Group
Deloitte advised on the accelerated refinancing and restructuring of Executive Care Group
Deloitte advised UDG Healthcare on the disposal of a group of unlicensed medicines businesses, the largest of which was The Specials Laboratory
The UK Deloitte Centre for Health Solutions
The UK Deloitte Centre for Health Solutions generates research and insights based on the key trends, challenges and opportunities across the healthcare and life sciences industry.
Please sign up to receive upcoming thought leadership publications, events and blogs from the UK Centre.